All In Biotech

Drug Trial Radar · NCT06312813

Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea

Pilot Studies Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea

Last checked: Nov 20, 2026Latest source record: Feb 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

48

Planned (sponsor's estimate)

Start

Feb 27, 2024

Primary completion

Dec 1, 2028

Study completion Dec 1, 2028

Sponsor

Lead sponsor
Wright State UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 15, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Rosacea is a common skin condition associated with easy blushing and red face; many patients with rosacea react to sunlight with increased redness. The purpose of this study is to determine if the use of a topical medication will help reduce sunlight induced redness and irritation in patients with rosacea.

Conditions

  • Rosacea

Interventions

  • ImipramineDrug

    4% imipramine

  • AmitriptylineDrug

    4% amitriptyline

  • VehicleDrug

    0.1ml propylene glycol

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Difference in redness of Ultraviolet B induced erythema with 4% imipramineTime frame: 10 minutes post-treatment
  2. Difference in redness of Ultraviolet B induced erythema with 4% imipramineTime frame: 60 minutes post-treatment
  3. Difference in redness of Ultraviolet B induced erythema with 4% imipramineTime frame: 120 minutes post-treatment
  4. Difference in redness of Ultraviolet B induced erythema with 4% imipramineTime frame: 24 hours post-treatment
  5. Difference in redness of Ultraviolet B induced erythema with 4% amitriptylineTime frame: 10 minutes post-treatment
  6. Difference in redness of Ultraviolet B induced erythema with 4% amitriptylineTime frame: 60 minutes post-treatment
  7. Difference in redness of Ultraviolet B induced erythema with 4% amitriptylineTime frame: 120 minutes post-treatment
  8. Difference in redness of Ultraviolet B induced erythema with 4% amitriptylineTime frame: 24 hours post-treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Wright State Physicians

    Fairborn, Ohio · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.